Drug Shortage Report for MYLAN-GLICLAZIDE MR

Last updated on 2024-07-09 History
Report ID 224058
Drug Identification Number 02438658
Brand name MYLAN-GLICLAZIDE MR
Common or Proper name GLICLAZIDE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 30MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100BT
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-03-21
Estimated end date 2024-07-30
Actual end date
Shortage status Actual shortage
Updated date 2024-07-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-07-09 French Compare
v11 2024-07-09 English Compare
v10 2024-07-03 French Compare
v9 2024-07-03 English Compare
v8 2024-05-17 French Compare
v7 2024-05-17 English Compare
v6 2024-04-16 French Compare
v5 2024-04-16 English Compare
v4 2024-04-09 French Compare
v3 2024-04-09 English Compare
v2 2024-04-01 French Compare
v1 2024-04-01 English Compare

Showing 1 to 12 of 12